| Financial Year |
March 31 2023 |
| Monetary Funds |
711,217,748.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
22,349,305.41 |
| Accounts Receivable |
546,801,168.93 |
| Advances to Suppliers |
241,949,959.76 |
| Other Receivables |
9,458,708.43 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
49,875,558.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,689,742.65 |
| Total Current Assets |
1,673,449,915.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
122,617,097.87 |
| Investment Properties |
-- |
| Fixed Assetes |
271,961,851.73 |
| Under-construction Projects |
143,122,922.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
82,879,115.96 |
| R&D expenses |
-- |
| Goodwill |
180,434,209.14 |
| Long-Term Deferred and Prepaid Expenses |
4,493,723.52 |
| Deferred Income Tax Assets |
7,543,477.74 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
814,994,678.26 |
| Total Assets |
2,488,444,593.26 |
| Short-Term Loans |
377,183,203.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
104,206,853.66 |
| Accounts Payable |
114,957,275.50 |
| Accounts Received In Advance |
1,702.65 |
| Employee Compensation Payable |
21,377,335.30 |
| Taxes Payable |
11,934,171.95 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
30,311,514.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
14,457,030.51 |
| Sub-Total of Current Liabilities |
759,529,522.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
197,482.83 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,585,454.15 |
| Total Liabilities |
771,114,976.93 |
| Paid-In Capital(Or Share Stock) |
320,040,000.00 |
| Capital Surplus |
714,687,690.36 |
| Surplus Reserve |
44,698,386.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
535,409,844.81 |
| Minority Stockholder's Interest |
102,493,694.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,614,835,921.90 |
| Owner's Equity（Stockholder's Equity） |
1,717,329,616.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,488,444,593.26 |
